Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

711 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Fractional flow reserve-guided multivessel angioplasty in myocardial infarction: three-year follow-up with cost benefit analysis of the Compare-Acute trial.
Smits PC, Laforgia PL, Abdel-Wahab M, Neumann FJ, Richardt G, Boxma-de Klerk B, Lunde K, Schotborgh CE, Piroth Z, Horak D, Wlodarczak A, Frederix GW, Omerovic E. Smits PC, et al. Among authors: neumann fj. EuroIntervention. 2020 Jun 25;16(3):225-232. doi: 10.4244/EIJ-D-20-00012. EuroIntervention. 2020. PMID: 32250250 Free article. Clinical Trial.
Sirolimus-eluting stent treatment at high-volume centers confers lower mortality at 6-month follow-up: results from the prospective multicenter German Cypher Registry.
Khattab AA, Hamm CW, Senges J, Toelg R, Geist V, Bonzel T, Kelm M, Levenson B, Nienaber CA, Pfannebecker T, Sabin G, Schneider S, Tebbe U, Neumann FJ, Richardt G; German Cypher Registry. Khattab AA, et al. Among authors: neumann fj. Circulation. 2009 Aug 18;120(7):600-6. doi: 10.1161/CIRCULATIONAHA.108.810333. Epub 2009 Aug 3. Circulation. 2009. PMID: 19652087
Bivalirudin vs. unfractionated heparin during percutaneous coronary interventions in patients with stable and unstable angina pectoris: 1-year results of the ISAR-REACT 3 trial.
Schulz S, Mehilli J, Ndrepepa G, Neumann FJ, Birkmeier KA, Kufner S, Richardt G, Berger PB, Schömig A, Kastrati A; Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment (ISAR-REACT) 3 Trial Investigators. Schulz S, et al. Among authors: neumann fj. Eur Heart J. 2010 Mar;31(5):582-7. doi: 10.1093/eurheartj/ehq008. Epub 2010 Feb 11. Eur Heart J. 2010. PMID: 20150324 Clinical Trial.
Statin effect on thrombin inhibitor effectiveness during percutaneous coronary intervention: a post-hoc analysis from the ISAR-REACT 3 trial.
Khattab AA, Ndrepepa G, Schulz S, Neumann FJ, Mehilli J, Büttner HJ, Pache J, Seyfarth M, Dirschinger J, Kastrati A, Berger PB, Schömig A, Richardt G. Khattab AA, et al. Among authors: neumann fj. Clin Res Cardiol. 2011 Jul;100(7):579-85. doi: 10.1007/s00392-011-0282-7. Epub 2011 Feb 11. Clin Res Cardiol. 2011. PMID: 21311899 Clinical Trial.
Drug-eluting versus bare-metal stents in saphenous vein graft lesions (ISAR-CABG): a randomised controlled superiority trial.
Mehilli J, Pache J, Abdel-Wahab M, Schulz S, Byrne RA, Tiroch K, Hausleiter J, Seyfarth M, Ott I, Ibrahim T, Fusaro M, Laugwitz KL, Massberg S, Neumann FJ, Richardt G, Schömig A, Kastrati A; Is Drug-Eluting-Stenting Associated with Improved Results in Coronary Artery Bypass Grafts? (ISAR-CABG) Investigators. Mehilli J, et al. Among authors: neumann fj. Lancet. 2011 Sep 17;378(9796):1071-8. doi: 10.1016/S0140-6736(11)61255-5. Epub 2011 Aug 26. Lancet. 2011. PMID: 21872918 Clinical Trial.
711 results